Table 3. Concomitant mutations of KRAS, NBAS, BRAF, and PIK3CA genes.
Genes | Tumors | PIK3CA exon 9 | PIK3CA exon 20 |
---|---|---|---|
KRAS+PIK3CA | 24 | 17 | 4 |
BRAF+PIK3CA | 4 | 1 | 2 |
NRAS+PIK3CA | 2 | 0 | 1 |
PIK3CA+PIK3CA | 2 | 1 | 0 |
KRAS+KRAS | la | ||
KRAS+BRAF | 3b | ||
KRAS+NBAS | 3c |
p.Gl2A and p.Gl3D.
KRAS p.Gl5S (c.43G4 A) and BRAF p.V600E (c.1799T4 A); KRAS p.A59E (c.l76C4 A) and BRAF p.D594G (c.1781A4 G); and KRAS p.G12V (c.35G4 T) and BRAF p.Y472C (c.1415A4 G).
KRAS p.Gl2D (c.354 G4 A) and NRAS p.Q61K (c.181C4 A); KRAS p.A146T (c.436G4 A) and NRAS p.Q61R (C.182A4 G); and KRAS p.G12V(c.35G4 T) and NRAS p.G13C (c.37G4 T).